Adverse Drug Reactions in Dental Practice
Adverse Drug Reactions in Dental Practice
Adverse Drug Reactions in Dental Practice
Adverse reactions may occur with any of the medications prescribed or administered
in dental practice. Most of these reactions are somewhat predictable based on the
pharmacodynamic properties of the drug. Others, such as allergic and pseudoallergic
reactions, are less common and unrelated to normal drug action. This article will
review the most common adverse reactions that are unrelated to drug allergy.
26
Anesth Prog 61:26–34 2014 Becker 27
In addition to respiratory influences, these drug classes Unlike diphenhydramine or hydroxyzine, prometha-
may also lower arterial blood pressure and heart rate. zine (Phenergan) also acts as a dopamine receptor
Cardiovascular influences are rarely significant at doses antagonist, an action shared by other antiemetic drugs
intended for minimal to deep sedation, but with doses such as prochlorperazine (Compazine) and droperidol
and combinations intended for general anesthesia the (Inapsine). Although dopamine receptor blockade within
risk for hypotension may become more substantial. A the chemoreceptor trigger zone provides an added
summary of respiratory and cardiovascular influences of antiemetic mechanism, this identical action within the
the most commonly used drugs is provided in Table 2. basal ganglia introduces the risk for extrapyramidal
Benzodiazepines and propofol produce anterograde syndromes. This is a collective term for several
amnesia when administered at sedative dosages.5 This is conditions including acute dystonia, akathisia, and
an inability to recall events that occur while conscious but Parkinsonism. Acute dystonias generally present as
under the influence of a medication. The term is not spasms of the tongue, facial, and neck muscles, whereas
applicable during general anesthesia because the patient akathisia presents as a subjective feeling of restlessness
is unconscious. Although anterograde amnesia is an and a compelling need to move about. These behaviors
attractive effect during unpleasant procedures, it may may be mistaken for agitation, and their distinction is
also be problematic should a need arise to alter a dental critical to avoid an inclination to further sedate the
treatment plan. These issues must be taken into account patient. Although extrapyramidal symptoms are bizarre,
prior to the procedure and the vested escort educated and generally frighten the patient and practitioner alike,
regarding the patient’s lack of judgment during recovery they are never life threatening. The added anticholiner-
at home. gic action of diphenhydramine is useful for countering
acute episodes should they occur.7
A final note on promethazine is worth mention. Like
ANTIHISTAMINES AND ANTIEMETICS
other phenothiazine as well as butyrophenone deriva-
tives, it has antagonist actions on vascular alpha
The antihistamines and related antiemetics are com-
receptors, which increases risk for postural hypotension,
monly used in regimens for procedural sedation but also
especially in the elderly.
are indicated for minor allergic reactions and nausea or
vomiting. When used alone they have little influence on
respiration, but they may potentiate respiratory depres- Table 2. Relative Respiratory and Cardiovascular Influences of
Selected Drugs4
sion produced by opioids and other sedatives. All of
these agents have anticholinergic action, but peripheral Heart Mean Arterial
side effects are rarely if ever encountered, although Ventilation Rate Pressure
mouth dryness might be a nuisance to some patients. Intravenous agents
Central cholinergic blockade can be another matter, Diazepam ++ ,** +
however. Cognition and memory are functions of Midazolam ++ ** ++
cholinergic neurotransmission, and degeneration of Methohexital +++ ** ++
Propofol +++ , ++
cholinergic neurons is the key component of Alzheimer’s Etomidate + , +
dementia. Drugs having central anticholinergic actions Ketamine ,+ ** **
should probably be avoided in elderly patients, particu- Fentanyl +++ ++ ,+
larly those having evidence of dementia.6 Moreover, Meperidine +++ * +
high doses of anticholinergic drugs can result in a Inhalation agents
‘‘central anticholinergic syndrome’’ that includes delirium Nitrous oxide , , ,
and combativeness. During lengthy treatment under Desflurane ++ ,* ++
Sevoflurane + , +
sedation it is important to not exceed conventionally
suggested doses for these agents. * Reflex increase due to decline in mean arterial pressure.
28 Adverse Drug Reactions in Dental Practice Anesth Prog 61:26–34 2014
LOCAL ANESTHETICS and avoid their use for nerve blocks, opting instead for
agents formulated in lower concentrations.10,11
Local anesthetics are remarkably safe when used in As local anesthetics are absorbed from the injection
proper doses and concentrations, but they are certainly site, their concentration in the bloodstream rises and the
capable of producing both local and systemic toxicity. peripheral and central nervous systems are depressed in a
Ischemic necrosis of tissues may follow injections of local dose-dependent manner.8 (See Figure 1.) Low serum
anesthetics. This can be due to the irritating nature of a concentrations are used clinically for suppressing cardiac
solution, pressure from large volumes, or constriction of arrhythmias and status seizures, but as their concentration
the vasculature by vasopressors. This concern is greatest rises, local anesthetics produce drowsiness. At higher
when injecting into attached mucosa such as the hard concentrations, convulsive seizures occur and are the
palate. There is also mounting concern regarding direct initial life-threatening consequence of local anesthetic
neurotoxicity related to formulations containing high overdose. This is presumably due to selective depression
concentrations, such as 4% articaine and prilocaine. of cortical inhibitory tracts allowing unopposed activity of
Local anesthetics can produce direct toxicity to nerve excitatory pathways.8,13 This selectivity is lost as serum
trunks, leading to persistent paresthesias. Although the concentrations rise even further and all pathways are
dental community has been slow to reach consensus inhibited, resulting in coma, respiratory arrest, and
regarding this issue, it should be appreciated that medical eventually cardiovascular collapse. Evidence of lidocaine
anesthesia literature is emphatic in claiming that greater toxicity may commence at serum concentrations .5 lg/
concentration of local anesthetic solutions increases risk mL, but convulsive seizures generally require concentra-
for direct neurotoxicity to nerve trunks: tions .10 lg/mL. If maximum recommended doses
published in conventional references are adhered to,
‘‘All the clinically used local anesthetics can produce excessive serum concentrations are unlikely to occur.
direct toxicity to nerves if they achieve sufficiently high It is essential that local anesthetics be respected as
intraneural concentrations. Clinicians should be aware central nervous system depressants, and they potentiate
that the concentrations of formulated local anesthetic any respiratory depression associated with sedatives and
solutions are neurotoxic per se and that their dilution, opioids. Furthermore, serum concentrations required to
in situ or in tissue, is essential for safe use.’’8 produce seizures are lower if hypercarbia (elevated carbon
Local anesthetic concentrations of 2% or 3% carry dioxide) is present. This is the case when respiratory
little risk, but 4% articaine and prilocaine formulations depression is produced by concurrent administration of
most certainly introduce added risk. Haas and Lennon sedatives and opioids. Goodson and Moore have docu-
first reported an increased incidence of paresthesias in mented catastrophic consequences of this drug interaction
Canada following the introduction of articaine in the mid- in pediatric patients receiving procedural sedation, along
1980s.9 When 4% articaine was first submitted for with excessive dosages of local anesthetics.14
approval to the Food and Drug Administration in the
United States, it was identified as having a higher risk for
paresthesia than 2% lidocaine.
More recently, Garisto et al10 reviewed claims of
paresthesia in the United States during the period of
November 1997 through August 2008 and found 248
cases of paresthesia following dental procedures. Most
cases (~95%) involved mandibular nerve blocks, and in
89% of these the lingual nerve was affected. Compared
to other local anesthetics, paresthesia was found to be
7.3 times more likely with 4% articaine and 3.6 times
more likely with 4% prilocaine. Similar findings from
reports of paresthesia in Denmark were published by
Hillerup et al11 and even more convincing is their
demonstration of greater neural toxicity for 4% com-
pared to 2% articaine in sciatic nerve preparations.12 As
with all drugs, each practitioner needs to perform a risk-
benefit analysis before using a medication. Only if the
benefit of using a 4% concentration outweighs the risk
for a patient should it be considered for use. It might be Figure 1. Approximate serum concentrations and systemic
wise to limit the use of 4% concentrations for infiltration influences of lidocaine.
Anesth Prog 61:26–34 2014 Becker 29
Although all local anesthetics carry similar risk for have been thoroughly reviewed in previous continuing
central nervous system toxicity, it should be noted that education articles in this journal.16,17 Epinephrine is the
bupivacaine exhibits greater potential for direct cardiac vasoconstrictor used most commonly, and produces the
toxicity than other agents.8,13 The explanation is not systemic cardiovascular effects illustrated in Figure 2.
fully established but is thought to be related to the fact Even small doses of epinephrine produce these cardio-
that bupivacaine has greater affinity for the inactive and vascular effects; this is unequivocal. At issue is the actual
resting sodium channel configurations and dissociates magnitude and whether or not these influences pose a
from these channels more slowly. This delays recovery significant risk to a particular patient. The most often
from action potentials, rendering cardiac tissues suscep- cited guidelines suggest that a 2-cartridge limit be
tible to arrhythmias. This concern is relevant for certain imposed for patients with cardiovascular disease, but
medical procedures during which bupivacaine is admin- this is naı̈ve. Ultimately, the decision requires the dentist
istered in very high doses. It has never been found to to exercise sound clinical judgment based on a thorough
occur with doses up to the maximum recommended in analysis of each patient under consideration.
dental anesthesia. Generally, the hemodynamic influences of epineph-
When considering the toxicity of any drug class, one rine are witnessed within 5 minutes of injection and have
should be mindful of metabolites, as well as the parent completely subsided in 10–15 minutes. If for any reason
drug. A metabolite of prilocaine, 0-toluidine, can oxidize the medical status of a patient is in question, a sensible
the iron in hemoglobin from ferrous (Fe2þ) to ferric protocol is to record baseline heart rate and blood
(Fe3þ). Hemes so altered do not bind oxygen, and normal pressure preoperatively and again following every 20–
hemes on the same hemoglobin molecule do not readily 40 lg administered (~1–2 cartridges containing a
release their oxygen. This form of hemoglobin is called 1 : 100,000 epinephrine concentration). Virtually any
methemoglobin, and when .1% of total hemoglobin is ambulatory patient can tolerate the cardiovascular
so altered, the condition is called methemoglobinemia. influences of this amount. If the patient’s vital signs
Patients appear cyanotic and become symptomatic remain stable for 5 minutes following injection, addition-
when the proportion of methemoglobin exceeds 15%. al doses may be administered and followed by a similar
Hemoglobin saturation by pulse oximetry will decline pattern of reassessing vital signs. One should also
despite clinical evidence of adequate oxygenation and consider using lower concentrations of epinephrine.
ventilation. At methemoglobin levels of up to 35%, Despite the popularity of epinephrine 1 : 100,000,
oxygen saturation via pulse oximetry decreases by an concentrations greater than 1 : 200,000 (5 lg/mL)
amount proportional to the concentration of methemo- offer little if any advantage. Greater concentrations do
globin until the latter reaches approximately 35%. At not provide better onset or duration for inferior alveolar
higher methemoglobin levels, the oxygen saturation nerve block.19,20 Nor do higher concentrations reduce
levels out at about 85%.15 The condition becomes life local anesthetic serum concentrations.21
threatening when methemoglobin levels exceed 50–
60%, and it is managed using intravenous methylene
blue, which reduces the hemes to their normal state.
Methemoglobinemia attributed to prilocaine is unlikely to
follow the administration of recommended doses.
Rarely, one may encounter a patient with hereditary
methemoglobinemia, which contraindicates the use of
prilocaine.
Vasoconstrictors are combined with local anesthetics to Figure 2. Cardiovascular influences of epinephrine. The graph
provide hemostasis in the operative field and to delay is adapted from Hersh et al.18 Average of cardiovascular
anesthetic absorption. This influence is mediated by changes were recorded following injection of 7 cartridges (11.9
activation of alpha-1 receptors on submucosal vascula- mL) of articaine containing either 1 : 100,000 or 1 : 200,000
ture, but, following systemic absorption, cardiovascular concentrations of epinephrine (~120 and 60 lg respectively).
Although actual changes were mild, consider that all volunteers
influences can result from their activation of additional were healthy young adults taking no medications. Even so, 2
adrenergic receptors as well. The doses and cardiovas- volunteers experienced palpitations. Also note confirmation of
cular influences of both epinephrine and levonordefrin the dose-dependent responses for 60 versus 120 lg.
30 Adverse Drug Reactions in Dental Practice Anesth Prog 61:26–34 2014
REFERENCES
C difficile Disease
1. Gomes ER, Demoly P. Epidemiology of hypersensitivity
C difficile is an anaerobic, spore-forming bacillus. It is drug reactions. Curr Opin Allergy Clin Immunol. 2005;5:
not regarded as a normal component of intestinal flora; it 309–316.
is present in only 1–4% of the general population. 2. Becker DE. Drug allergies and implications for dental
practice. Anesth Prog. 2013;60:188–197.
However, it can be found in .20% of patients admitted
3. American Society of Anesthesiologists Task Force on
for a week or more to health care facilities where it Sedation and Analgesia by Non-Anesthesiologists. Practice
resides as a nosocomial pathogen.33,34 Nevertheless, guidelines for sedation and analgesia by non-anesthesiologists.
community sources for C difficile are on the rise. Anesthesiology. 2002;96:1004–1017.
Normal intestinal flora will typically prevent coloniza- 4. Butterworth JF IV, Mackey DC, Wasnick JS. Morgan &
tion by C difficile, but antibiotics can diminish this Mikhail’s Clinical Anesthesiology. 5th ed. New York, NY:
protection. If a patient either harbors or comes into Lange Medical Books/McGraw Hill; 2013.
contact with C difficile, colonization may supervene. 5. Veselis RA, Reinsel RA, Feshchenko VA, Wronski M.
Two recent meta-analyses revealed the odds ratios for C The comparative amnestic effects of midazolam, propofol,
difficile infection to be 16.8–20.4 for clindamycin, 4.5– thiopental, and fentanyl at equisedative concentrations. Anes-
thesiology. 1997;87:749–764.
5.7 for cephalosporins, and 2.7–3.2 for penicillins.
6. Dierdorf SF, Walton JS. Anesthesia for patients with
Neither study found an increased risk for tetracy- rare and co-existing diseases. In: Barash PG, Cullen BF,
clines.35,36 It should be clarified that colonization alone Stoelting RK, eds. Clinical Anesthesia. 5th ed. Philadelphia,
does not necessarily result in C difficile infection. Risk PA: JB Lippincott Co; 2006.
for actual infection depends on the interaction of several 7. Vinson DR, Drotts DL. Diphenhydramine for the
additional factors, including virulence of the particular prevention of akathisia induced by prochlorperazine: a
strain and patient-related factors such as age, immune randomized, controlled trial. Ann Emerg Med. 2001;37:
status, and the concurrent use of acid-reduction GI drugs, 125–131.
eg, proton pump inhibitors. Actual consequences of C 8. Berde CB, Strichartz GR. Local anesthetics. In: Miller
difficile infection range from diarrhea to pseudomem- RD, Eriksson LI, Fleisher LA, et al, eds. Miller’s Anesthesia.
7th ed. Philadelphia, PA: Elsevier, Churchill Livingstone;
branous colitis.
2009.
In a patient who normally tolerates antibiotics but 9. Haas DA, Lennon D. A 21 year retrospective study of
experiences diarrhea that is florid (3 unformed stools reports of paresthesia following local anesthetic administration.
per day for 2 days) and complains of abdominal pain, J Can Dent Assoc. 1995;61:319–330.
C difficile infection should be suspected, and the 10. Garisto GA, Gaffen AS, Lawrence HP, Tenenbaum HC,
following protocol is suggested.31,33,37 Haas DA. Occurrence of paresthesia after dental local
Anesth Prog 61:26–34 2014 Becker 33
anesthetic administration in the United States. J Am Dent 24. Goldenberg NA, Jacobson MT, Manco-Johnson MJ.
Assoc. 2010;141:836–844. Duration of platelet dysfunction after a 7-day course of
11. Hillerup S, Jensen RH, Ersboll BK. Trigeminal nerve ibuprofen. Ann Intern Med. 2005;142:506–509.
injury associated with injection of local anesthetics: needle 25. DeBroe ME, Elseviers MM. Analgesic nephropathy. N
lesion or neurotoxicity? J Am Dent Assoc. 2011;142:531– Engl J Med. 1998;338:446–452
539 26. Abramowicz M, ed. Acetaminophen safety—deja vu.
12. Hillerup S, Bakke M, Larsen JO, Thomsen CE, Gerds Med Lett Drugs Ther. 2009;51:53.
TA. Concentration-dependent neurotoxicity of articaine: an 27. Grosser T, Smyth E, Fitzgerald GA. Anti-inflammatory,
electrophysiological and stereological study of the rat sciatic antipyretic, and analgesic agents; pharmacotherapy of gout. In:
nerve. Anesth Analg. 2011;112:1330–1338. Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and
13. Katzung BG, White PF. Local anesthetics. In: Katzung Gilman’s the Pharmacological Basis of Therapeutics. 12th
BG, Masters SB, Trevor AJ, eds. Basic and Clinical ed. New York, NY: McGraw-Hill Companies Inc; 2011.
Pharmacology. 11th ed. New York, NY: The McGraw-Hill 28. Apfel CC. Postoperative nausea and vomiting. In: Miller
Companies Inc; 2009. RD, Eriksson LI, Fleisher LA, et al, eds. Miller’s Anesthesia.
14. Goodson JM, Moore PA. Life-threatening reactions 7th ed. Philadelphia, PA: Elsevier, Churchill Livingstone;
after pedodontic sedation: an assessment of narcotic, local 2009.
anesthetic and antiemetic drug interactions. J Am Dent Assoc. 29. Yaksh TL, Wallace MS. Opioids, analgesia, and pain
1983;107:239–245. management. In: Brunton LL, Chabner BA, Knollmann BC,
15. Barker SJ, Tremper KK, Hyatt J. Effects of methemo- eds. Goodman and Gilman’s the Pharmacological Basis of
Therapeutics. 12th ed. New York, NY: McGraw-Hill Compa-
globinemia on pulse oximetry and mixed venous oximetry.
nies Inc; 2011.
Anesthesiology. 1989;70:112–117
30. Abramowicz M, ed. Drugs for pain. Treat Guidel Med
16. Becker DE, Reed KL. Local anesthetics: review of
Lett. 2007;5:23–32.
pharmacological considerations. Anesth Prog. 2012;59:90–
31. Bartlett JG. Clinical practice. Antibiotic-associated
102.
diarrhea. N Engl J Med. 2002;346:334–339.
17. Becker DE. Basic and clinical pharmacology of auto-
32. Hempel S, Newberry SJ, Maher AR. et al. Probiotics for
nomic drugs. Anesth Prog. 2012;59:159–168.
the prevention and treatment of antibiotic-associated diarrhea:
18. Hersh EV, Giannakopoulos H, Levin LM, et al. The
a systematic review and meta-analysis. JAMA. 2012;307:
pharmacokinetics and cardiovascular effects of high-dose 1959–1969.
articaine with 1 : 100,000 and 1 : 200,000 epinephrine. J 33. Gerding DN, Johnson S. Clostridium difficile-associat-
Am Dent Assoc. 2006;137:1562–1571. ed disease, including pseudomembranous colitis. In: Longo DL,
19. Dagher FB, Yared GM, Machtou P. An evaluation of 2% Fauci AS, Kasper DL, et al, eds. Harrison’s Principles of
lidocaine with different concentrations of epinephrine for Internal Medicine. 18th ed. New York, NY: McGraw Hill;
inferior alveolar nerve block. J Endod. 1997;23:178–180. 2012.
20. Tofoli GR, Ramacciato JC, de Oliveira PC, et al. 34. Kelly CP. A 76-year-old man with recurrent Clostridi-
Comparison of effectiveness of 4% articaine associated with um difficile–associated diarrhea: review of C difficile infec-
1 : 100,000 or 1 : 200,000 epinephrine in inferior alveolar tion. JAMA. 2009;301:954–962
nerve block. Anesth Prog. 2003;50:164–168. 35. Brown KA, Khanafer N, Daneman N, Fisman DN.
21. Scott DB, Jebson PJR, Braid DP, et al. Factors affecting Meta-analysis of antibiotics and the risk of community-
plasma levels of lignocaine and prilocaine. Br J Anaesth. associated Clostridium difficile infection. Antimicrob Agents
1972;44:1040–1049. Chemother. 2013;57:2326–2332.
22. Kimmey MB. Cardioprotective effects and gastrointes- 36. Deshpande A, Pasupuleti V, Thota P, et al. Community-
tinal risks of aspirin: maintaining the delicate balance. Am J associated Clostridium difficile infection and antibiotics a
Med. 2004;117:72s–78s. meta-analysis. J Antimicrob Chemother. 2013;68:1951–
23. Delaney JA, Opatrny L, Brophy JM, Suissa S. Drug- 1961.
drug interactions between antithrombotic medications and the 37. Abramowicz M, ed. Treatment of Clostridium difficile
risk of gastrointestinal bleeding. CMAJ. 2007;177:347–351. infection. Med Lett Drugs Ther. 2011;1358:14–15.
34 Adverse Drug Reactions in Dental Practice Anesth Prog 61:26–34 2014